Pharma investors put less skin in the game as risk appetite wanes https://t.co/izXtjWQ7PM via @FT

Pharma investors put less skin in the game as risk appetite wanes https://t.co/izXtjWQ7PM via @FT

— The Propell Group (@ThePropellGroup) April 10, 2017

#healthtech